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Solid Phase Peptide Synthesis:
Analysis and Identification of Protein Kinase Substrates
Abstract
This research study examines the synthesis
of tyrosine containing peptides based on
the protein paxillin. Paxillin is a proposed
substrate of the Focal Adhesion Kinase
(FAK) protein tyrosine kinase. FAK is
overexpressed in tumor cells; therefore, its
abnormal function is associated with several
cancer types. The peptides designed here
are based on the substrate sequence FAK
preferably binds to and phosphorylates.
Solid Phase Peptide Synthesis (SPPS)
provided substrate compounds which were
then tested via biological assays with FAK.
The synthesis of large peptides provides an
accurate method to determine kinase amino
acid phosphorylation preference to confirm
paxillin as a FAK substrate.
Derrick Kroodsma
McNair Scholar

Laurie A. Witucki, Ph.D.
Faculty Mentor

Introduction
Cancer is the second leading cause
of death in the United States. About
570,280 Americans are expected to
die of cancer in 2005, more than
1,500 people per day.1 There are
numerous factors which contribute to
the oncogenesis of cells and a better
understanding of these variables may
one day lead to improved cancer
treatments. One such factor is abnormal,
over expression of certain types of
enzymes called protein tyrosine kinases
(PTK). A kinase may be thought of as
a “chemical switch” since it chemically
alters its substrates by covalently
attaching a phosphate (PO3-2) group
to them. Once phosphorylated, these
substrate enzymes may be turned “on”
or turned “off.” A specific kinase is
FAK2 (See Figure 1.) FAK, located in the
mammalian cell membrane, has been
associated with several cancer types,
including lung and breast cancer3-4 (See
Figure 2.) A proposed substrate for FAK
is paxillin. A substrate can be thought
of as a key which fits a kinase lock. The
protein paxillin is a ligand that binds to
membrane bound receptors that trigger
cellular transduction pathways. FAK
functions in regulation of cell adhesion
and that trigger cellular transduction
pathways. FAK functions in regulation
of cell adhesion and migration by
phosphorylating a tyrosine residue (Y)
in paxillin (See Figure 3.) Within the
amino acid sequence of paxillin, there
are many possible tyrosines, which
can be phosphorylated by FAK (See
Figure 4.) The aim of this project is to
focus on the tyrosine in paxillin and
synthesize short versions of the paxillin
protein around this targeted residue.
While proteins are larger (longer)
chains of amino acids, peptides are
short chains of 2-100 amino acids
(See Figure 5.) The peptides for this
research project include a specific

Abbreviations: FAK, focal adhesion kinase; PTK, protein tyrosine kinase, ATP, adenosine triphosphate; SPPS, solid phase peptide synthesis; Fmoc,
9-fluorenylmethoxycarbonyl; HOBt, hydroxybenzotriazole hydride; HBTU, 2-(1 H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate;
TFA, trifluroacetic acid; TIS, triisopropylsaline
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tyrosine from the paxillin sequence,
Y118 (Residue number 118). This was
chosen based on previous Western
blots using anti-paxillin antibody
indicating that phosphorylation may
occur at this tyrosine location.5-7 This
study synthesized, via SPPS, tyrosine
containing paxillin peptides.8 A general
tyrosine peptide sequence is:
H2N-aa7-aa6-aa5-Y-aa3-aa2-aa1-COOH.
H2N = N-terminal
COOH = C-terminal
Testing a synthesized peptide with
the kinase FAK will provide a more
accurate quantitative determination of
the extent of phosphorylation instead
of the qualitative Western blot analysis.
This study will also investigate varying
lengths of peptides surrounding tyrosine
118; the range of sizes is from 12-30
amino acids in length. Testing with FAK
will determine if it is possible to have 12
amino acid peptides act as a substrate
for this kinase.

Methods
Solid Phase Peptide Synthesis (SPPS)
The peptide synthesis was automated
with an Advanced Chemtech peptide
synthesizer. Table 1 shows the target
peptides for this study.
Polylysine (K) tails were attached
to the C-terminal end of each peptide
for adhesion to the negatively charged
phosphocellulose paper disks used
during assaying.9 The γ-phosphate is
transferred to the tyrosine residue from
ATP to produce the phosphorylated
tyrosine YP, and ADP. This is measured
quantitatively with γ-P32 ATP. The Cterminal of each peptide is bonded
to a 90µm diameter polymer resin
bead called Wang (100-200 mesh).10
Each amino acid attached to the
peptide initially contains an N-α-Fmoc
protection group and amino acids
may also contain side chain protecting
groups11-12 (See Figure 6 for chemical
structures of reagents) and (See Figure 7
for steps of SPPS.) To ensure successive
amino acid coupling before Fmoc

deprotection, a three-fold excess of each
amino acid was used. The Fmoc group
was “deprotected” or removed with
piperidine before each coupling step.
Activation of the amino acid’s carboxy
group was done with HOBt and HBTU.
A ninhydrin test was performed to
confirm complete lysine coupling to the
resin.13 Each peptide used 0.25 g of the
polylysine resin. All of the other amino
acids were attached as described above
by the automated Advanced Chemtech
peptide synthesizer. The continuous,
computerized process handles larger
peptides without compromising either
purity or the product yield. Upon
completion, the Wang resin and any
amino acid side chain protecting groups
were cleaved and deprotected by TFA
and scavengers.14-15 Once cleaved, the
solid peptides were obtained, rinsed,
and dried. The amounts and percent
yield are shown in Table 2.

Table 1. Description of Target Peptides
Target Peptide
Peptide #1
Peptide #2
Peptide #3

Sequence
E114EHVY118SFPN122KKK
V111GEEEHVY118SFPNKQK125KK
G105SPCSRVGEEEHVY118SFPNKQKSAEPSP131KKK

Molecular Weight
MW: 1249.5847 g/mol
MW: 2047.0607 g/mol
MW: 3330.6535 g/mol

Length
12-mer
17-mer
30-mer

Results
Table 2. Analysis of Peptides
Target Peptide
Peptide #1
Peptide #2
Peptide #3

94

Grams Obtained
0.160
0.135
02.63

Percent Yield
76.4%
39.4%
47.1%
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Discussion
Three peptides were successfully
synthesized by SPPS on an automated
peptide synthesizer. The peptides are
in 3 successively increasing lengths
that are identical to the structure in
paxillin around Y118. The purpose
is to determine, through biological
assaying, which peptide best represents
an actual substitution for paxillin. If
the rates of phosphorylation on Y118
are indistinguishable between the
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12-mer and 30-mer peptides, then
it is reasonable to synthesize smaller
peptides for future research. Future
research using these peptides will be a
confirmation of the peptide structure
by Edman sequencing and mass
spectrometry. Biological assaying against
FAK, using γ-ATP32, will quantify the
phosphorylation rate on Y118. The
numerical results would help determine
if Y118 is the tyrosine FAK preferably
binds to within paxillin.

Knowledge gained through
research such as this would assist the
pharmaceutical industry by providing
a tool that could be used to screen
thousands of possible drug molecules.
Although these peptides are neither drugs
nor treatments, therapeutic agents could
be developed for FAK-related cancers.
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Figure 1. A 3-dimensional crystal structure of FAK in ribbon structure. The peptide
substrate is absent but ATP is shown in the center in ball & stick notation.
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Figure 2. Location of FAK within a cell and a cellular process it participates in.
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Figure 3. Cartoon representation of a tyrosine kinase phosphorylation reaction.

Figure 4. This full amino acid sequence of the paxillin protein was used to derive the
synthesized peptides. The 30 amino acids underlined above correspond to peptide #3 in Table 1.
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Figure 5. A general amino acid structure is shown on the left and a dipeptide structure is shown on the
right. Peptides are chains of repeating units (amino acids) connected together by amide bonds (circled).

Figure 6. Chemical structures of reagents used during peptide synthesis via SPPS.
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Figure 7. Chemical structures of reagents used during peptide synthesis via SPPS.
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